What is Roth Capital’s Estimate for BRTX Q2 Earnings?
BioRestorative Therapies, Inc. (NASDAQ:BRTX – Free Report) – Equities researchers at Roth Capital lowered their Q2 2025 EPS estimates for BioRestorative Therapies in a report issued on Wednesday, May 14th. Roth Capital analyst J. Aschoff now expects that the company will post earnings of ($0.41) per share for the quarter, down from their prior estimate […]
BioRestorative Therapies, Inc. (NASDAQ:BRTX – Free Report) – Equities researchers at Roth Capital lowered their Q2 2025 EPS estimates for BioRestorative Therapies in a report issued on Wednesday, May 14th. Roth Capital analyst J. Aschoff now expects that the company will post earnings of ($0.41) per share for the quarter, down from their prior estimate […]
